Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Change in Receivables came in at $3.5 million in Q4 2025, up 1876.0% YoY from $175000.0 in Q4 2024, and up 0.52% on a QoQ basis from $3.4 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 3 years of Change in Receivables data on file, last reported at $3.5 million in Q4 2025.
- Quarterly Change in Receivables rose 1876.0% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (up 58.01% YoY) and the FY2025 annual result came in at $12.4 million, up 58.01% from the prior year.
- Change in Receivables climbed to $3.5 million in Q4 2025, from $3.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $5.3 million in Q1 2025 to a low of $138000.0 in Q1 2023.
- A 3-year average of $2.3 million and a median of $2.1 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables tumbled 95.92% — and 2025, when it soared 1876.0%.
- Tracing FENC's Change in Receivables over 3 years: stood at $4.3 million in 2023, then plunged by 95.92% to $175000.0 in 2024, then soared by 1876.0% to $3.5 million in 2025.
- The last three Change in Receivables figures came in at $3.5 million (Q4 2025), $3.4 million (Q3 2025), and $265000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.46 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 5.28 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 175,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 4.20 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.08 Mn |